Amyris Inc (NASDAQ:AMRS) had its Buy rating reiterated by HC Wainwright with a $15.00 price target

ME Staff
-
0

Analyst Ratings For Amyris Inc (NASDAQ:AMRS)

Today, HC Wainwright reiterated its Buy rating on Amyris Inc (NASDAQ:AMRS) with a price target of $15.00.

There are 2 Buy Ratings, 1 Hold Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.

The current consensus rating on Amyris Inc (NASDAQ:AMRS) is Buy with a consensus target price of $9.6667 per share, a potential 42.58% upside.

Some recent analyst ratings include

  • 8/7/2018-HC Wainwright Reiterated Rating of Buy.
  • 11/29/2017-Cowen Reiterated Rating of Hold.
  • 1/11/2017-Rodman & Renshaw Reiterated Rating of Buy.
  • 9/28/2016-Singular Research Reiterated Rating of Buy.

Recent Insider Trading Activity For Amyris Inc (NASDAQ:AMRS)
Amyris Inc (NASDAQ:AMRS) has insider ownership of 21.80% and institutional ownership of 23.68%.

  • On 7/16/2018 John Melo, Insider, sold 22,355 with an average share price of $6.61 per share and the total transaction amounting to $147,766.55.
  • On 5/7/2018 (Mauritius) Pte Ltd Maxwell, Major Shareholder, sold 95,162 with an average share price of $6.54 per share and the total transaction amounting to $622,359.48.
  • On 1/16/2018 John Melo, Insider, sold 10,776 with an average share price of $4.68 per share and the total transaction amounting to $50,431.68.
  • On 5/19/2017 Patrick Y Yang, Director, bought 300,000 with an average share price of $0.29 per share and the total transaction amounting to $87,000.00.
  • On 4/20/2017 (Mauritius) Pte Ltd Maxwell, Major Shareholder, sold 652,513 with an average share price of $0.55 per share and the total transaction amounting to $358,882.15.
  • On 4/18/2017 (Mauritius) Pte Ltd Maxwell, Major Shareholder, sold 1,636,930 with an average share price of $0.65 per share and the total transaction amounting to $1,064,004.50.
  • On 3/30/2017 (Mauritius) Pte Ltd Maxwell, Major Shareholder, sold 184,535 with an average share price of $0.51 per share and the total transaction amounting to $94,112.85.

About Amyris Inc (NASDAQ:AMRS)
Amyris, Inc. provides various alternatives to a range of petroleum-sourced products worldwide. The company uses its industrial bioscience technology to design microbes primarily yeast, as well as to convert plant-sourced sugars into renewable ingredients. It produces and sells Biofene that converts to squalane, which is used as an emollient in cosmetics and other personal care products; and natural oils and aroma chemicals for the flavors and fragrances market. The company also provides renewable solvents, polymers, and lubricants for industrial markets; Biofene ingredients for nutraceuticals and vitamins market; and renewable fuels for transportation fuels markets. It has a collaboration partnership with Total S.A. to produce and commercialize Biofene-based diesel and jet fuels. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was founded in 2003 and is headquartered in Emeryville, California.

Recent Trading Activity for Amyris Inc (NASDAQ:AMRS)
Shares of Amyris Inc closed the previous trading session at 6,78 −0,090 1,31 % with 6.76 shares trading hands.